(148 days)
The TRUCLEAR Tissue Removal Devices are intended for intrauterine use by trained gynecologists to hysteroscopically resect and remove tissue such as: Submucous myomas Endometrial polyps Retained products of conception
Smith & Nephew's TRUCLEAR ULTRA Mini Tissue Removal Device is a single use device that hysteroscopically removes intra-uterine tissue. The device consists of a stainless steel inner tube that rotates and reciprocates inside a stainless steel outer tube. The proximal ends of the tubes are enclosed within a plastic housing. The housing is engaged with the TRUCLEAR Handpiece which drives the inner tube of the device. The inner tube has a sharp cutting edge that resects tissue in the cutting window at the distal end of the outer tube. The resected tissue is simultaneously aspirated out of the uterine cavity using suction.
The provided text describes a 510(k) premarket notification for a medical device called the "TRUCLEAR ULTRA Mini Tissue Removal Device." This document focuses on demonstrating the substantial equivalence of the new device to a predicate device through various non-clinical bench tests. However, it does not include information about a study proving the device meets acceptance criteria related to human-in-the-loop performance, multi-reader multi-case studies, standalone algorithm performance, or the establishment of ground truth by multiple experts for an AI/algorithm-based device.
The listed tests (Shed Test, Cutting Performance Test, Resection Rate Test, Biocompatibility Testing, Shelf Life Testing) are all bench tests evaluating the physical and functional performance of the device itself (e.g., blade wear, cutting durability, tissue removal speed, material safety, and shelf life). They are not clinical studies involving human patients or complex image analysis that would require the establishment of ground truth by experts or evaluate human reader performance with or without AI assistance.
Therefore, I cannot provide the requested information for acceptance criteria and studies demonstrating performance in the context of human-in-the-loop or AI-assisted medical device performance, as the provided document pertains to a physical surgical device with mechanical and material performance testing.
To elaborate, the document indicates:
- Device Type: A hysteroscopic tissue removal device, which is a physical surgical instrument.
- Performance Tests: Focus on mechanical function (cutting, shedding, resection rate), material safety (biocompatibility), and stability (shelf life).
- Context: 510(k) submission for substantial equivalence to a predicate device, based on bench testing.
The information necessary to answer your specific questions (e.g., number of experts, adjudication methods, MRMC studies, standalone algorithm performance, ground truth for training/test sets) is entirely absent because the device and the nature of the submitted data do not involve AI, image analysis, or diagnostic interpretation that would necessitate such studies.
§ 884.1690 Hysteroscope and accessories.
(a)
Identification. A hysteroscope is a device used to permit direct viewing of the cervical canal and the uterine cavity by a telescopic system introduced into the uterus through the cervix. It is used to perform diagnostic and surgical procedures other than sterilization. This generic type of device may include obturators and sheaths, instruments used through an operating channel, scope preheaters, light sources and cables, and component parts.(b)
Classification. (1) Class II (performance standards).(2) Class I for hysteroscope accessories that are not part of a specialized instrument or device delivery system; do not have adapters, connectors, channels, or do not have portals for electrosurgical, laser, or other power sources. Such hysteroscope accessory instruments include: lens cleaning brush, cannula (without trocar or valves), clamp/hemostat/grasper, curette, instrument guide, forceps, dissector, mechanical (noninflatable), and scissors. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 884.9.